Main menu

Ph.D. Defense

Jiawei Wang defended her Ph.D. dissertation “Drug -Free Macromolecular Therapeutics as a B Cell Depletion Strategy” on January 26th, 2021.

Recent Publications

M.T. Gambles, J. Li, J. Wang, D. Sborov, J. Yang, J. Kopeček, Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells. Molecules 26, 4658 (2021); doi.
J. Wang, J. Yang, J. Kopeček, Nanomedicines in B Cell-Targeting Therapies. Acta Biomater. 137, 1-19 (2022); doi
M.T. Gambles, J. Li, D.C. Radford, D. Sborov, P. Shami, J. Yang, J. Kopeček, Simultaneous Crosslinking of CD20 and CD38 Receptors by Drug-Free Macromolecular Therapeutics Enhances B Cell Apoptosis In Vitro and In Vivo. J. Controlled Release 350, 584-599 (2022); doi
Z.-H. Peng, C.M. Jogdeo, J. Li, Y. Xie, Y. Wang, Y.M. Sheinin, J. Kopeček, D. Oupický, Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model. Pharmaceutics 14, 1725 (2022); doi
M.T. Gambles, J. Yang, J. Kopeček, Multi-Targeted Immunotherapeutics to Treat B Cell Malignancies. J. Controlled Release 358, 232-258 (2023); doi